| Trial ID: | L0665 |
| Source ID: | JPRN-UMIN000006197
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Therapeutic fficacy of sitagliptin in patients with nonalcoholic fatty liver disease (NAFLD)in impaired glucose tolerance (IGT): a pilot study
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease
|
| Interventions: |
administration of sitagliptin (50mg daily)
|
| Outcome Measures: |
Before and after 6 months of sitagliptin (50mg daily) to nonalcoholic fatty liver disease (NAFLD) patients, we assessed hepatic transaminase and ultrasonographic featuresnan
|
| Sponsor/Collaborators: |
Iwasaki Naika Clinic
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Phase 3
|
| Enrollment: |
20
|
| Study Type: |
Interventional
|
| Study Designs: |
Single arm Non-randomized
|
| Start Date: |
01/09/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007311
|
